Repairing mutated proteins - development of small molecules targeting defects in the cystic fibrosis transmembrane conductance regulator

Author： Merk Daniel Schubert-Zsilavecz Manfred

Publisher： Informa Healthcare

ISSN： 1746-0441

Source： Expert Opinion on Drug Discovery, Vol.8, Iss.6, 2013-10, pp. : 691-708

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stimulation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels by flavonoids

By Illek B. Machen T.E. Widdicombe J. Fischer H.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 1-4

Informa Healthcare

Access to resources Recommend Favorite

[(Dihydroindenyl)oxy]alkaonic acid inhibits the cystic fibrosis transmembrane conductance regulator

By Ito Y. Aoyama M. Yamada N. Mizuno Y. Kume H. Yamaki K.

European Journal of Pharmacology, Vol. 426, Iss. 3, 2001-08 ,pp. : 175-178

Elsevier

Access to resources Recommend Favorite

Cystic fibrosis transmembrane conductance regulator mutations in azoospermic and oligospermic men and their partners

By Gallati Sabina Hess Simone Galié-Wunder Dorothea Berger-Menz Elisabeth Böhlen Dominik

Reproductive BioMedicine Online, Vol. 19, Iss. 5, 2009-11 ,pp. : 685-694

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

The therapeutic potential of the human cystic fibrosis transmembrane conductance regulator gene

By Pavirani A.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 9, 1997-09 ,pp. : 1187-1192

Informa Healthcare

Access to resources Recommend Favorite

Cystic Fibrosis Transmembrane Conductance Regulator Modulators for Personalized Drug Treatment of Cystic Fibrosis: Progress to Date

By Becq Frédéric

Drugs, Vol. 70, Iss. 3, 2010-02 ,pp. : 241-259

Adis International

Access to resources Recommend Favorite